simvastatin has been researched along with Vitreoretinopathy, Proliferative in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hartmann, D; Kassumeh, S; Ohlmann, A; Priglinger, SG; Strehle, L; Tersi, N; Wertheimer, CM; Wolf, A | 1 |
| Arita, R; Enaida, H; Goto, Y; Hafezi-Moghadam, A; Hata, Y; Ishibashi, T; Kagimoto, T; Kawahara, S; Kita, T; Miura, M; Mochizuki, Y; Nakao, S | 1 |
2 other study(ies) available for simvastatin and Vitreoretinopathy, Proliferative
| Article | Year |
|---|---|
Pharmacological Therapy of Proliferative Vitreoretinopathy: Systematic
Topics: Dasatinib; Humans; Resveratrol; Retinal Pigment Epithelium; Simvastatin; Vitreoretinopathy, Proliferative | 2023 |
Potent inhibition of cicatricial contraction in proliferative vitreoretinal diseases by statins.
Topics: Animals; Biological Transport; Blotting, Western; Cattle; Cell Membrane; Cells, Cultured; Collagen; Diabetic Retinopathy; Electroretinography; Enzyme-Linked Immunosorbent Assay; Humans; Hypolipidemic Agents; In Situ Nick-End Labeling; Microscopy, Electron, Transmission; Myosin Light Chains; Phosphorylation; Retina; rho GTP-Binding Proteins; Simvastatin; Transforming Growth Factor beta2; Vitreoretinopathy, Proliferative; Vitreous Body | 2008 |